Ovarian cancer news on how hormone receptor expression can help determine cancer progression. A new study investigated the impact of mRNA and protein expression of follicle-stimulating hormone and luteinizing hormone receptors on ovarian cancer progression, using publicly available online databases, qRTPCR and immunohistochemistry.
High receptor expression in patients with all subtypes of high-grade ovarian cancer was significantly associated with longer progression-free survival and overall survival.